Literature DB >> 3600937

Composition of mesangial deposits in IgA nephropathy: complement factors.

M C Bene, G C Faure.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3600937     DOI： 10.1159/000184350

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  8 in total

1.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

2.  IgA nephropathy associated with a novel N-terminal mutation in factor H.

Authors:  Roland Schmitt; Rafael T Krmar; Anncharlotte Kristoffersson; Magnus Söderberg; Diana Karpman
Journal:  Eur J Pediatr       Date:  2010-08-24       Impact factor: 3.183

3.  Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.

Authors:  Minhua Xie; Yuze Zhu; Xutong Wang; Jingjing Ren; Haonan Guo; Bo Huang; Shulei Wang; Peiheng Wang; Yiming Liu; Yingchun Liu; Junjun Zhang
Journal:  J Nephrol       Date:  2022-07-04       Impact factor: 3.902

4.  An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Authors:  R K Stad; J A Bruijn; D J van Gijlswijk-Janssen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma.

Authors:  M E van den Dobbelsteen; V Verhasselt; J G Kaashoek; J J Timmerman; W E Schroeijers; C L Verweij; F J van der Woude; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy.

Authors:  Teodora Ioana Flavia Paunas; Kenneth Finne; Sabine Leh; Hans-Peter Marti; Tom Eirik Mollnes; Frode Berven; Bjørn Egil Vikse
Journal:  Clin Proteomics       Date:  2017-08-14       Impact factor: 3.988

7.  Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort.

Authors:  Suceena Alexander; George T John; Anila Korula; T S Vijayakumar; Vinoi George David; Anjali Mohapatra; Anna T Valson; Shibu Jacob; Pradeep Mathew Koshy; Gautam Rajan; Elenjickal Elias John; Smita Mary Matthai; L Jeyaseelan; Babu Ponnusamy; Terence Cook; Charles Pusey; Mohamed R Daha; John Feehally; Jonathan Barratt; Santosh Varughese
Journal:  Wellcome Open Res       Date:  2018-07-26

8.  Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients.

Authors:  Yen-Ling Chiu; Wei-Chou Lin; Kai-Hsiang Shu; Yi-Wen Fang; Fan-Chi Chang; Yu-Hsiang Chou; Ching-Fang Wu; Wen-Chih Chiang; Shuei-Liong Lin; Yung-Ming Chen; Ming-Shiou Wu
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.